GAITHERSBURG, Md., July 23, 2020 /PRNewswire/ — Shreis Scalene Therapeutics LLC (SSTx), a MD-USA-based medical device company will fast-track the manufacture and distribution of the CE-marked (EU-Class 1) Scalene Hypercharge Corona Canon (SHYCOCAN) under US FDA ‘Enforcement Policy for Sterilizers, Disinfectant Devices, and Air Purifiers During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency.”
{iframe}https://www.biospace.com/article/releases/shycocan-a-device-to-disable-coronaviruses-to-be-marketed-under-us-fda-s-enforcement-discretion-during-the-covid-19-public-health-emergency/{/iframe}